[{"Assets_0_Q3_USD":239145771.0,"CommonStockSharesOutstanding_0_Q3_shares":56242571.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-86762574.0,"NetIncomeLoss_1_Q3_USD":-35972115.0,"NetIncomeLoss_3_Q3_USD":-91042720.0,"StockholdersEquity_0_Q3_USD":195954850.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]